Epsilon M&A Deal Report - Nanoscribe
Transaction Multiples for the Valuation of Private Companies
Cellink / Nanoscribe
No EMAT :
105542
Announced Date :
19/05/2021
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Cellink
Target :
Nanoscribe
Country :
Germany
Sector of activity :
- Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Equipment
Business Description :
Founded in 2007 by scientists and PhD Students from Karlsruhe Institute of Technology (KIT), Nanoscribe Holding GmbH ("Nanoscribe") focuses on development of high-precision 3D printers based on...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
||
| Current |
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Equipment » = 225
| Date | Acquirer | Target | Country | Multiples | See details |
| 23/04/2021 | Private Group led by Naxicap Partners | Lagarrigue | Haute-Garonne | * | 105539 |
| 20/01/2021 | Private Group Led by Montagu Private Equity LLP | IMV Technologies | Orne | * | 104661 |
Source: Epsilon Research / EMAT
